The Cell and Gene Therapy Catapult (CGT Catapult) is an independent not-for-profit innovation and technology organisation committed to the advancement of cell and gene therapies.
The CGT Catapult has compiled information on market access processes for cell and gene therapies in the major European markets. On this page, you will find reimbursement roadmaps for:
- Roadmap for England and Wales
- Roadmap for Spain
- Roadmap for Italy
- Roadmap for France
- Roadmap for Germany
